Portal de Periódicos da CAPES

Discovery of Protein–Protein Interaction Inhibitors of Replication Protein A

2013; American Chemical Society; Volume: 4; Issue: 7 Linguagem: Inglês

10.1021/ml400032y

1948-5875

James D. Patrone, J. Phillip Kennedy, Andreas O. Frank, Michael D. Feldkamp, Bhavatarini Vangamudi, Nicholas F. Pelz, Olivia W. Rossanese, Alex G. Waterson, Walter Chazin, Stephen W. Fesik,

Genomics and Chromatin Dynamics

Replication Protein A (RPA) is a ssDNA binding protein that is essential for DNA replication and repair. The initiation of the DNA damage response by RPA is mediated by protein-protein interactions involving the N-terminal domain of the 70 kDa subunit with partner proteins. Inhibition of these interactions increases sensitivity towards DNA damage and replication stress and may therefore be a potential strategy for cancer drug discovery. Towards this end, we have discovered two lead series of compounds, derived from hits obtained from a fragment-based screen, that bind to RPA70N with low micromolar affinity and inhibit the binding of an ATRIP-derived peptide to RPA. These compounds may offer a promising starting point for the discovery of clinically useful RPA inhibitors.